Bacteremia: all 297 studies

Page 3 of 3. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre StudyCompletedNCT02128139
• A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental ProceduresCompletedNCT02115776Not applicable
• Results of Bile and Blood Culture in Patients With Acute CholangitisTerminatedNCT02107560
• Staphylococcus Aureus Bacteraemia in AdultsStatus unknownNCT02098850
• Treatment of Hemodialysis Catheter-Related BacteremiaWithdrawnNCT02040818Phase 2/3
• Virulence of Staphylococcus Lugdunensis in Severe InfectionsCompletedNCT02026895Not applicable
• Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or SepsisCompletedNCT02025699
• Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by EnterobacteriaceaeCompletedNCT02005159
• Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) BacteremiaTerminatedNCT01975662Phase 2
• Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular EpidemiologyCompletedNCT01971762
• Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)CompletedNCT01919762
• Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in ChildrenCompletedNCT01919593Phase 4
• Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA BacteremiaCompletedNCT01898338Phase 3
• Immune Resolution After Staphylococcus Aureus BacteremiaActive, not recruitingNCT01879761
• Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic ShockCompletedNCT01867905
• Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological PatientsTerminatedNCT01820962Phase 3
• Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired InfectionsStatus unknownNCT01798537Phase 2/3
• Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational StudyCompletedNCT01764490
• Duration of Antibiotics for the Treatment of Gram-negative Bacilli BacteremiaCompletedNCT01737320Not applicable
• Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to CeftarolineStatus unknownNCT01724671
• Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus BacteremiaCompletedNCT01701219Phase 4
• PVP Iodine Effect on Post Debridement BacteraemiaCompletedNCT01647347Phase 4
• Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTATerminatedNCT01640886
• Concentration of Antimicrobials in Catheter-lock SolutionsStatus unknownNCT01592032Phase 4
• Immune Response of Patients With Chronic, Staphylococcus Aureus-infected WoundsCompletedNCT01551667
• Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA BacteremiaTerminatedNCT01515020Phase 3
• Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.CompletedNCT01450358Phase 4
• Multicenter Blood Culture Quality ImprovementCompletedNCT01413555Not applicable
• The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUOCompletedNCT01410578
• Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot StudyCompletedNCT01394458Not applicable
• Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility ChangeStatus unknownNCT01392118
• Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - BrandenburgTerminatedNCT01388686
• Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature NeonatesTerminatedNCT01365312Not applicable
• Exercise in Critically Ill Patients With SepsisStatus unknownNCT01364909Not applicable
• Clinical Evaluation of Novel Biomarkers in Patients With SepticemiaCompletedNCT01359891
• Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin TherapyStatus unknownNCT01352936
• Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive InfectionsStatus unknownNCT01301638
• Establish Quantitative PCR to Measure Bacteria Load of the VRE BacteremiaStatus unknownNCT01265095
• Clarithromycin as Immunomodulator for the Management of SepsisCompletedNCT01223690Phase 3
• Rapid Test to Detect Staphylococcus Aureus in Blood and Wound InfectionsCompletedNCT01198262
• Ethanol Lock for the Salvage of Infected Long-term Vascular AccessStatus unknownNCT01186172Phase 3
• Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture PositivesCompletedNCT01184339
• Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial LesionsCompletedNCT01179022
• Daptomycin Pharmacokinetics in Continuous Veno-venous HemodiafiltrationStatus unknownNCT01171547Phase 2
• Improved Detection of Neonatal Sepsis Using a Targeted Biomarker AssayCompletedNCT01120678
• Balloon-assisted Enteroscopy and BacteriaStatus unknownNCT01065324
• The Impact of Material on Microbiota in Association With Tongue and Lip PiercingCompletedNCT01039259
• Increasing the Yield of Blood Cultures in NeonatesCompletedNCT01023555Not applicable
• Clinical Trial to Reduce Antibiotic Resistance in European Intensive CaresCompletedNCT00976638Not applicable
• Effectiveness of Routine Sterile Gloving in Blood CultureCompletedNCT00973063Not applicable
• Comparison of Infection Rates Among Patients Using Two Catheter Access DevicesCompletedNCT00965198
• Bacteremia in Intensive Care Unit (ICU)Status unknownNCT00932243
• Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile NeutropeniaCompletedNCT00913042
• HeRO Vascular Access Device Bacteremia StudyCompletedNCT00889564Not applicable
• HeRO Vascular Access Device Post Market Procedural Survey ProtocolCompletedNCT00889291
• Central Venous Catheter Lock SolutionStatus unknownNCT00862966Not applicable
• Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and InflammationTerminatedNCT00835783
• MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta TrialCompletedNCT00814151
• Dental Study in Cancer Patients With Central Venous CathetersCompletedNCT00798330
• Taurolidine Lock Solution in the Prevention of Catheter Related BacteremiaCompletedNCT00735813Phase 3
• Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino ChildrenCompletedNCT00724828
• Procalcitonin Level and Kinetics in Children With Bacterial InfectionsCompletedNCT00714402
• Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a SourceCompletedNCT00692848Not applicable
• UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters TunnelingStatus unknownNCT00639197Not applicable
• Early Infectious Disease Consultations in Staphylococcus Aureus BacteremiaStatus unknownNCT00622882Not applicable
• Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing RegimenCompletedNCT00609375Phase 4
• Combination Therapy With Fluoroquinolone in Staphylococcus Aureus BacteremiaCompletedNCT00548002
• Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine DihydrochlorideCompletedNCT00515151Phase 4
• A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. EpidermidisWithdrawnNCT00509847Phase 1/2
• Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus BacteremiaWithdrawnNCT00505258Phase 2
• Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial InfectionsStatus unknownNCT00502476
• Bacteria Entering the Blood Stream From Tooth Extractions and Tooth BrushingCompletedNCT00454285Phase 2
• The Impact of Chlorhexidine-Based Bathing on Nosocomial InfectionsCompletedNCT00448942
• Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous InfusionTerminatedNCT00435305
• Colombia Epidemiologic Surveillance StudyTerminatedNCT00428051
• Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU PatientsCompletedNCT00417235Phase 4
• Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract OriginCompletedNCT00414362
• Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-LactamaseCompletedNCT00414193
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe SepsisCompletedNCT00406198Phase 4
• Infections Caused by ESbL-Producing Enterobacteriaceae in ItalyStatus unknownNCT00404625
• Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective StudyStatus unknownNCT00326313
• Virulence Determinants in S Aureus BacteremiaCompletedNCT00319826
• Prevention of Bacteremia Induced by Debridement of Pressure UlcerTerminatedNCT00269100
• Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)CompletedNCT00235690Not applicable
• Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)CompletedNCT00198302Phase 2
• Pharmacodynamic Parameters of Two Different Doses of CefepimeCompletedNCT00177736
• The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot StudyTerminatedNCT00164099Phase 4
• Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired InfectionsCompletedNCT00130221Phase 1
• Alcohol Locks for the Prevention of Tunneled Catheter-related InfectionsCompletedNCT00122642Phase 2/3
• Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusCompletedNCT00093067Phase 3
• Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream InfectionsStatus unknownNCT00057369Phase 2
• Daptomycin for the Treatment of Infections Due to Gram-Positive BacteriaTerminatedNCT00055198Phase 3
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream InfectionsCompletedNCT00027248Phase 3
• Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.CompletedNCT00002192Phase 2
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND StudyCompletedNCT00002080Not applicable
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionCompletedNCT00000895Not applicable

← Bacteremia overview